Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07589023 · ClinicalTrials.gov registry record
A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis
A clinical trial, sponsored by Globus Medical.
- Not yet
- Registry status
- 100
- Enrollment target
NCT07589023: Clinical Trial study, sponsored by Globus Medical.
NCT07589023 is a clinical trial that has not yet begun recruiting, run by Globus Medical. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07589023 has not yet begun recruiting, sponsored by Globus Medical.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study reviews medical records of children and adolescents treated for idiopathic scoliosis (a sideways curve of the spine with no known cause) using the REFLECT™ Scoliosis Correction System.
Primary Outcome
Comparison of REFLECT cord breakage/separation rate (radiographically suspected or confirmed) in 4.0 mm vs. 5.0 mm cords
Interventions
- DEVICE Scoliosis Correction System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-07-31 |
What is known before NCT07589023 opens enrollment
NCT07589023 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Scoliosis Correction System is the first listed.
NCT07589023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07589023 about?
NCT07589023 is a clinical study titled "A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis". This study reviews medical records of children and adolescents treated for idiopathic scoliosis (a sideways curve of the spine with no known cause) using the REFLECT™ Scoliosis Correction System.
What is the current status of trial NCT07589023?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-06-15. Estimated completion is 2027-07-31.
What interventions are being tested in trial NCT07589023?
The interventions under investigation include: Scoliosis Correction System (DEVICE).
Who is sponsoring clinical trial NCT07589023?
This trial is sponsored by Globus Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI